Pimavanserina 34 mg placebo cápsulas, Pimavanserin tartrate clinical trials

Antidepressant effects of psilocybin in the absence of serotoninergic psychedelic experience: a dimensional functional neuroimaging approach

This study is looking into a new medication called pimavanserin for major depression. It aims to see if this drug can help improve depression by looking at brain activity, even if participants don't feel the 'psychedelic' effects typically associated with some other treatments.